H-Pro-OtBuCAS# 2812-46-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 2812-46-6 | SDF | Download SDF |
| PubChem ID | 102884 | Appearance | Powder |
| Formula | C9H17NO2 | M.Wt | 171.2 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | tert-butyl pyrrolidine-2-carboxylate | ||
| SMILES | CC(C)(C)OC(=O)C1CCCN1 | ||
| Standard InChIKey | XJJBXZIKXFOMLP-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C9H17NO2/c1-9(2,3)12-8(11)7-5-4-6-10-7/h7,10H,4-6H2,1-3H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
H-Pro-OtBu Dilution Calculator
H-Pro-OtBu Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 5.8411 mL | 29.2056 mL | 58.4112 mL | 116.8224 mL | 146.028 mL |
| 5 mM | 1.1682 mL | 5.8411 mL | 11.6822 mL | 23.3645 mL | 29.2056 mL |
| 10 mM | 0.5841 mL | 2.9206 mL | 5.8411 mL | 11.6822 mL | 14.6028 mL |
| 50 mM | 0.1168 mL | 0.5841 mL | 1.1682 mL | 2.3364 mL | 2.9206 mL |
| 100 mM | 0.0584 mL | 0.2921 mL | 0.5841 mL | 1.1682 mL | 1.4603 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
H-Pro-OtBu
- Pluviatolide
Catalog No.:BCN3041
CAS No.:28115-68-6
- Adamantane
Catalog No.:BCN8481
CAS No.:281-23-2
- Chaetocin
Catalog No.:BCC2429
CAS No.:28097-03-2
- (+)-Ulopterol
Catalog No.:BCN1228
CAS No.:28095-18-3
- A 286982
Catalog No.:BCC3946
CAS No.:280749-17-9
- SB 216763
Catalog No.:BCC3650
CAS No.:280744-09-4
- VUF 5574
Catalog No.:BCC7030
CAS No.:280570-45-8
- Rediocide A
Catalog No.:BCN5175
CAS No.:280565-85-7
- Piperazine Ferulate
Catalog No.:BCN3277
CAS No.:171876-65-6
- 2,6-Bis(2-benzimidazolyl)pyridine
Catalog No.:BCC8504
CAS No.:28020-73-7
- 25-O-methylcimigenol-3-O-beta-D-xylopyranoside
Catalog No.:BCN1464
CAS No.:27994-13-4
- Cimigenoside
Catalog No.:BCN5174
CAS No.:27994-11-2
- 8-Aminoadenine
Catalog No.:BCC6108
CAS No.:28128-33-8
- Peonidin-3-O-galactoside chloride
Catalog No.:BCN3027
CAS No.:28148-89-2
- CHC
Catalog No.:BCC7994
CAS No.:28166-41-8
- Futoquinol
Catalog No.:BCN6416
CAS No.:28178-92-9
- 5-Amino-2-mercaptobenzimidazole
Catalog No.:BCC8730
CAS No.:2818-66-8
- Sinensin
Catalog No.:BCN4797
CAS No.:28189-90-4
- Dihydrodehydrodiconiferyl alcohol
Catalog No.:BCN5176
CAS No.:28199-69-1
- Lauterine
Catalog No.:BCN7062
CAS No.:28200-65-9
- JTE 907
Catalog No.:BCC7380
CAS No.:282089-49-0
- Phlorin
Catalog No.:BCN5177
CAS No.:28217-60-9
- HOOBt
Catalog No.:BCC2817
CAS No.:28230-32-2
- Reynosin
Catalog No.:BCN5178
CAS No.:28254-53-7
Synthesis, radiolabeling and biological activity of peptide oostatic hormone and its analogues.[Pubmed:9309578]
J Pept Res. 1997 Sep;50(3):153-8.
A series of Pro peptides containing the sequence of the oostatic hormone 3d and its shorter analogues 3a-3c differing in a number of the C-terminal Pro residues was prepared for a study of its effect on oogenesis in Sarcophaga bullata Parker (Diptera). Peptides 3a-3d were synthesized in solution by the fragment condensation of Boc-Tyr-Asp(OtBu)-Pro-Ala-Pro-OH (2f) with Pro oligopeptides H-(Pro)2-5-OtBu. The amino-terminal protected pentapeptide acid 2f was prepared by a stepwise procedure from TFA.H-Ala-Pro-OMe using Boc-Pro-OH, Z-Asp(OtBu)-OSu and Boc-Tyr-OSu. The H(Z)-(Pro)2-5-OtBu oligopeptides 1a-1h were synthesized from Z-Pro-OH and H-Pro-OtBu by a combination of stepwise procedure and fragment condensation. The 125I-labeled molecules of the octapeptide 3b and decapeptide 3d were used for radiotracer distribution studies. Evidence of content of the labeled peptide material in various parts of the insect body (ovaries, head, intestine) is presented. The time distribution of the labeled material in the insect organs was correlated with results of histological analysis of ovaries treated by nonlabeled peptides. The peptides assayed affected processes of egg development in 20-60% of ovarioles. The decapeptide 3d caused changes consisting in some resorbed egg chambers and normal appearance of vitellogenic eggs, whereas the octapeptide 3b caused abnormal yolk deposition and formation of big eggs with irregular yolk granules, proliferation of follicular epithelium in some egg chambers and about the same amount of resorbed egg chambers as decapeptide. These structural differences are complementary to the different values of organ radioactivities.
